An overview of this week's top business stories, with Aaron Task, executive editor of thestreet.com; Dan Primack, editor-at-large of Private Equity Week; and CNBC's Joe Kernen
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.